Stocklytics Platform
Asset logo for symbol DXCM
DexCom
DXCM81
$80.18arrow_drop_up1.09%$0.87
High Quality
S&P500
Asset logo for symbol DXCM
DXCM81

$80.18

arrow_drop_up1.09%

Performance History

Chart placeholder
Key Stats
Open$79.00
Prev. Close$79.31
EPS1.65
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
LOWHIGH
Day Range78.12
80.28
52 Week Range62.34
142.00
Ratios
EPS1.65

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About DexCom (DXCM)

DexCom Inc (DXCM) is a medical technology company that specializes in the design, development, and commercialization of continuous glucose monitoring (CGM) systems for people with diabetes. The company's CGM systems provide real-time glucose readings, allowing individuals to better manage their blood sugar levels. With its innovative technology, DexCom has revolutionized the way diabetes is managed and has become a leader in the industry.
Over the years, DexCom has achieved significant growth, both in terms of revenue and market share. The company's stock price history reflects this success, with steady increases in value. Investors have been drawn to DXCM due to its strong financial performance and potential for future growth.
Sector
Healthcare
Industry
Medical Devices
CEO
Mr. Kevin Ronald Sayer
Headquarters
San Diego
Employees
7500
Exchange
NASDAQ
add DexCom  to watchlist

Keep an eye on DexCom

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the 52-week high and low for DexCom (DXCM)?

For DexCom (DXCM), the 52-week high is $142, which is 77.1% from the current price. The 52-week low is $62.34, the current price is 28.62% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

What is DexCom 's (DXCM) price per share?

The current price per share for DexCom (DXCM) is $80.18. The stock has seen a price change of $0.87 recently, indicating a 1.1% change. This reflects the stock's recent market performance and investor sentiment.
help

Is DexCom (DXCM) a growth stock?

DexCom (DXCM) has shown an average price growth of -2.35% over the past three years. It has received a score of 24 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying DexCom as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is DexCom (DXCM) stock price performance year to date (YTD)?

As of the latest data, DexCom (DXCM) has a year-to-date price change of -34.86%. Over the past month, the stock has experienced a price change of 15.04%. Over the last three months, the change has been 10.81%. Over the past six months, the figure is -30.42%. Looking at a longer horizon, the five-year price change stands at 43.23%.
help

Is DexCom (DXCM) a profitable company?

DexCom (DXCM) has a net income of $541.5M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 63.19% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 15.29% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $3.62B, with a revenue growth rate of 24.49%, providing insight into the company's sales performance and growth. The gross profit is $2.29B. Operating income is noted at $597.7M. Furthermore, the EBITDA is $975.3M.
help

What is the market capitalization of DexCom (DXCM)?

DexCom (DXCM) has a market capitalization of $32.07B. The average daily trading volume is 79.29, indicating the stock's liquidity and investor engagement.

Take Your Investments to a Whole New Level